Ecliptasaponin A ameliorates DSS-induced colitis in mice by suppressing M1 macrophage polarization via inhibiting the JAK2/STAT3 pathway
NIU Minzhu
YIN Lixia
QIAO Tong
YIN Lin
ZHANG Keni
HU Jianguo
SONG Chuanwang
GENG Zhijun
LI Jing
Abstract：Objective To investigate the effect of ecliptasaponin A(ESA)for alleviating dextran sulfate sodium(DSS)-induced inflammatory bowel disease(IBD)in mice and the underlying mechanism.Methods Twenty-four male C57BL/6 mice(8-10 weeks old)were equally randomized into control group,DSS-induced IBD model group,and DSS+ESA(50 mg/kg)treatment group.Disease activity index(DAI),colon length and spleen index of the mice were measured,and intestinal pathology was examined with HE staining.The expressions of inflammatory mediators(TNF-α,IL-6,and iNOS)in the colon mucosa were detected using ELISA and RT-qPCR,and intestinal barrier integrity was assessed using AB-PAS staining and by detecting ZO-1 and claudin-1 expressions using immunofluorescence staining and Western blotting.In cultured RAW264.7 macrophages,the effects of treatment with 50 μmol/L ESA,alone or in combination with 20 μmol/L RO8191(a JAK2/STAT3 pathway activator),on M1 polarization of the cells induced by LPS and IFN-γ stimulation and expressions of JAK2/STAT3 pathway proteins were analyzed using flow cytometry and Western blotting.Results In the mouse models of DSS-induced IBD,ESA treatment significantly alleviated body weight loss and colon shortening,reduced DAI,spleen index and histological scores,and ameliorated inflammatory cell infiltration in the colon tissue.ESA treatment also suppressed TNF-α,IL-6 and iNOS expressions,protected the goblet cells and the integrity of the mucus and mechanical barriers,and upregulated the expressions of ZO-1 and claudin-1.ESA treatment obviously decreased CD86+M1 polarization in the mesenteric lymph nodes of IBD mice and in LPS and IFN-γ-induced RAW264.7 cells,and significantly reduced p-JAK2 and p-STAT3 expressions in both the mouse models and RAW264.7 cells.Treatment with RO8191 caused reactivation of JAK2/STAT3 and strongly attenuated the inhibitory effect of ESA on CD86+polarization in RAW264.7 cells.Conclusion ESA alleviates DSS-induced colitis in mice by suppressing JAK2/STAT3-mediated M1 macrophage polarization and mitigating inflammation-driven intestinal barrier damage.
Keywords：ecliptasaponin Ainflammatory bowel diseaseintestinal barriermacrophage polarizationJAK2/STAT3
Publication Date：2025-06-20
Online Publishing Date：2025-08-15(First online date of this platform, not the publication date of the document)
Pages：10( 1297-1306 )